Novartis Cancer Drug Gets Marketing Recommendation from European Medicines Agency

Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?

Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?

Novartis Shareholders Give Green Light to Sandoz Spinoff

Bausch + Lomb Launches Proposed Financing for Xiidra Acquisition

Novartis's Sandoz to Commercialize Autoimmune Disorders Antibody in Europe, North America

Sandoz 1H Net Sales to Third Parties $4.8B

How Novartis’s CEO Learned From Mistakes and Got Help From an Unlikely Quarter

How Novartis’s CEO Learned From Mistakes and Got Help From an Unlikely Quarter

Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations

Novartis's Leqvio Injection Effective at Reducing Cholesterol Longer Term

Novartis's Sandoz Gets FDA Approval for Multiple Sclerosis Biosimilar

Regeneron Hits A New Record High On The Approval That 'Could Not Come Soon Enough'

Why This Regeneron Approval 'Could Not Come Soon Enough' As Novartis Looms

Novartis to Spin Off Sandoz in October -- Update

Novartis Sets Sandoz Spinoff Date for Oct. 4

Novartis Unit Sandoz Says Biosimilar Aflibercept Mylight Phase III Study Met Endpoint

Drugmaker Zoetis Stock Shows Rising Relative Strength

Novartis's Remibrutinib Trials For Chronic Urticaria Meet Primary Endpoint

Merck Stock Today: Why A Bear Call Spread Places $111 In Your Pocket Today